Skip to main content
Clinical Trials/CTRI/2023/04/052061
CTRI/2023/04/052061Not yet recruitingNot Applicable

A comparative study between Pericapsular nerve group block and femoral nerve blockusing ropivacaine 0.2% 25ml for ease of positioning to central neuraxial block in HIPsurgeries

ESIC Medical college and hospital1 site in 1 country78 target enrollmentStarted: January 5, 2023Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
78
Locations
1
Primary Endpoint
1.Efficacy of PENG block

Study Overview

Brief Summary

PURPOSE : A comparative study between Pericapsular nerve group block and Femoral nerve block using 25ml of 0.2% Ropivacaine for ease of positioning to central neuraxial block for Hip surgeries.

DESIGN : RANDOMIZED,CONTROLLED TRAIL

PARTICIPANT AND CONTROL : Patients undergoing Hip surgeries will be Randomly allocated to one of the two groups based on computer generated random number.

INTERVENTION : Site of injection is marked, under strict aseptic precautions and USG guided 25ml Local anaesthetic agent is administered after negative aspiration.

Inj. Ropivacaine 0.2% 25ml is administered in incremental dose after negative aspiration for every 5ml using 22G Spinal needle or 10cm stimiplex block needle.

Group P will receive 25mls of 0.2% Ropivacaine for pericapsular nerve group block

Group F will receive 25mll of 0.2% Ropivacaine for femoral nerve block

Vitals and VAS score is monitored from time of injection till position for central neuraxial block.

Pain Score and Angle of sitting position to administer central neuraxial block is noted.

MAIN OUTCOME MEASURES : Efficacy of Pericapsular nerve group block for positioning of patient for central neuraxial block

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Participant, Investigator and Outcome Assessor Blinded

Eligibility Criteria

Ages
50.00 Year(s) to 90.00 Year(s) (—)
Sex
Male

Inclusion Criteria

  • Patients of either sex, 2) 50–90 years of age, 3) American Society of Anesthesiologists (ASA) physical grading I–III were included in the study.

Exclusion Criteria

  • Exclusion criteria included patient refusal to participate in the study, 2) Presence of any coagulation disorders, 3) Presence of multiple fractures, 4) Any patients with head injury or other injuries,.

Outcomes

Primary Outcomes

1.Efficacy of PENG block

Time Frame: 40mins

2.Ease of positioning for central neuraxial block

Time Frame: 40mins

Secondary Outcomes

  • not applicable(not applicable)

Investigators

Sponsor
ESIC Medical college and hospital
Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials